1:41 am Novartis’ INSTEAD study for Onbrez Breezhaler in patients with moderate COPD meets primary objective – HedgeChatter

1:41 am Novartis’ INSTEAD study for Onbrez Breezhaler in patients with moderate COPD meets primary objective

28 Apr

1:41 am Novartis’ INSTEAD study for Onbrez Breezhaler in patients with moderate COPD meets primary objective

Bystocknews NVS, stock Comments Off

View todays social media effects on NVS

View the latest stocks trending across Twitter. Click to view dashboard

See who Novartis is hiring next, click here to view

Author